158 related articles for article (PubMed ID: 27345788)
41. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
[TBL] [Abstract][Full Text] [Related]
42. Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia.
Borrego-Écija S; Antonell A; Puig-Butillé JA; Pericot I; Prat-Bravo C; Abellan-Vidal MT; Mallada J; Olives J; Falgàs N; Oliva R; Lladó A; Sánchez-Valle R
Ann Clin Transl Neurol; 2019 Aug; 6(8):1559-1565. PubMed ID: 31402617
[TBL] [Abstract][Full Text] [Related]
43. Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family.
Narożańska E; Jasińska-Myga B; Sitek EJ; Robowski P; Brockhuis B; Lass P; Dubaniewicz M; Wieczorek D; Baker M; Rademakers R; Wszolek ZK; Sławek J
Eur J Neurol; 2011 Mar; 18(3):535-7. PubMed ID: 20561037
[TBL] [Abstract][Full Text] [Related]
44. A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.
Iyer A; Lapointe NE; Zielke K; Berdynski M; Guzman E; Barczak A; Chodakowska-Żebrowska M; Barcikowska M; Feinstein S; Zekanowski C
PLoS One; 2013; 8(9):e76409. PubMed ID: 24086739
[TBL] [Abstract][Full Text] [Related]
45. de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia.
Ando K; Ferlini L; Suain V; Yilmaz Z; Mansour S; Le Ber I; Bouchard C; Leroy K; Durr A; Clot F; Sarazin M; Bier JC; Brion JP
Acta Neuropathol Commun; 2020 Jun; 8(1):94. PubMed ID: 32600421
[No Abstract] [Full Text] [Related]
46. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
[TBL] [Abstract][Full Text] [Related]
47. The human MAPT locus generates circular RNAs.
Welden JR; van Doorn J; Nelson PT; Stamm S
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2753-2760. PubMed ID: 29729314
[TBL] [Abstract][Full Text] [Related]
48. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
49. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
[TBL] [Abstract][Full Text] [Related]
50. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
[TBL] [Abstract][Full Text] [Related]
51. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
[TBL] [Abstract][Full Text] [Related]
52. Generation of an integration-free induced pluripotent stem cell line, FJMUi001-A, from a hereditary spastic paraplegia patient carrying compound heterozygous p.P498L and p.R618W mutations in CAPN1 (SPG76).
Lu YQ; Dong EL; Yang WQ; Lai LL; Lin XH; Ma LX; Chen WJ; Wang N; Lin X
Stem Cell Res; 2019 Jan; 34():101354. PubMed ID: 30611022
[TBL] [Abstract][Full Text] [Related]
53. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage.
Bidollari E; Rotundo G; Ferrari D; Candido O; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Ilari A; Squitieri F; Vescovi AL; Rosati J
Stem Cell Res; 2018 Apr; 28():145-148. PubMed ID: 29486399
[TBL] [Abstract][Full Text] [Related]
54. Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegeneration.
Esteras N; Rohrer JD; Hardy J; Wray S; Abramov AY
Redox Biol; 2017 Aug; 12():410-422. PubMed ID: 28319892
[TBL] [Abstract][Full Text] [Related]
55. [Dementia study using induced pluripotent stem cells].
Matsuzono K; Abe K; Inoue H
Nihon Rinsho; 2016 Mar; 74(3):443-50. PubMed ID: 27025084
[TBL] [Abstract][Full Text] [Related]
56. Frontotemporal dementia phenotype associated with MAPT gene duplication.
Rovelet-Lecrux A; Hannequin D; Guillin O; Legallic S; Jurici S; Wallon D; Frebourg T; Campion D
J Alzheimers Dis; 2010; 21(3):897-902. PubMed ID: 20634582
[TBL] [Abstract][Full Text] [Related]
57. Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.
Whitwell JL; Boeve BF; Weigand SD; Senjem ML; Gunter JL; Baker MC; DeJesus-Hernandez M; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Jack CR; Josephs KA
Eur J Neurol; 2015 May; 22(5):745-52. PubMed ID: 25683866
[TBL] [Abstract][Full Text] [Related]
58. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B.
Zhang Y; Schmid B; Nikolaisen NK; Rasmussen MA; Aldana BI; Agger M; Calloe K; Stummann TC; Larsen HM; Nielsen TT; Huang J; Xu F; Liu X; Bolund L; Meyer M; Bak LK; Waagepetersen HS; Luo Y; Nielsen JE; ; Holst B; Clausen C; Hyttel P; Freude KK
Stem Cell Reports; 2017 Mar; 8(3):648-658. PubMed ID: 28216144
[TBL] [Abstract][Full Text] [Related]
59. Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon?
Sitek EJ; Narozanska E; Barczak A; Jasinska-Myga B; Harciarek M; Chodakowska-Zebrowska M; Kubiak M; Wieczorek D; Konieczna S; Rademakers R; Baker M; Berdynski M; Brockhuis B; Barcikowska M; Zekanowski C; Heilman KM; Wszolek ZK; Slawek J
Neurocase; 2014; 20(1):69-86. PubMed ID: 23121543
[TBL] [Abstract][Full Text] [Related]
60. Generation of a human induced pluripotent stem cell line (PSHi002-A) from a Treacher-Collins syndrome patient carrying a TCOF1 gene mutation (c.1966_1969dup).
Zhang Z; Si N; Pan B; Jiang H
Stem Cell Res; 2021 Aug; 55():102437. PubMed ID: 34247110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
